Global and United States Antiviral Agents EyeDrops Market 2020 | Industry Size, Growth Opportunities, Competitive Analysis and Forecast to 2025

Report Description

Comprehensive enlightenment in the Global and United States Antiviral Agents EyeDrops Market, addressing growing demand, production volume, sales revenue, and growth prospects.

The Global and United States Antiviral Agents EyeDrops Market research report of Pharmaceuticals and Healthcare industry offers an in-depth evaluation of each crucial aspect of the worldwide Antiviral Agents EyeDrops industry that relates to market size, share, revenue, demand, sales volume, and development in the market. The report analyzes the Antiviral Agents EyeDrops market over the values, historical pricing structure, and volume trends that make it easy to predict growth momentum and precisely estimate forthcoming opportunities in the Antiviral Agents EyeDrops industry.

The report also evaluates driving forces of Antiviral Agents EyeDrops market and changing dynamics which have been considered as growth-boosting factor. Also, the Antiviral Agents EyeDrops study sheds light on limitations and restraints that could probably become obstruction while the Antiviral Agents EyeDrops industry is proceeding to achieve substantial revenue. The report also aids readers to gain in-depth knowledge of a Antiviral Agents EyeDrops market environment that comprises terms such as entry barriers, and trading policies as well as regulatory, political, financial and social concerns that may also hamper Antiviral Agents EyeDrops market growth momentum.

Global and United States Antiviral Agents EyeDrops market overview in brief:

The Antiviral Agents EyeDrops market has been reporting substantial growth rates with considerable CAGR for the last couple of decades. According to the report, the Antiviral Agents EyeDrops market is expected to grow more vigorously during the forecast period and it can also influence the global economic structure with a higher revenue share. The Antiviral Agents EyeDrops market also holds the potential to impact its peers and parent Antiviral Agents EyeDrops market as the growth rate of the market is being accelerated by increasing product demand, growing disposable incomes, innovative products, raw material affluence, and changing consumption technologies.

Leading segments of the global and United States Antiviral Agents EyeDrops market with reliable forecasts:

Later the Antiviral Agents EyeDrops report studies decisive segments of the market, including applications, Antiviral Agents EyeDrops types, technologies, end-users, and regions. It explains the importance and performance of each Antiviral Agents EyeDrops segment considering demand, revenue share, growth prospects and sales volume. Also, the analysis helps the clients accurately determine the Antiviral Agents EyeDrops market size to be targeted and forecast evaluation guide them in selecting remunerative segments that will drive Antiviral Agents EyeDrops business growth in the near future.

The Leading Players involved in global and United States Antiviral Agents EyeDrops market are:

Novartis AG
Alcon
Bausch & Lomb Inc
Allergan, Inc.
Visine
Meda Pharmaceuticals Inc
Bausch & Lomb
Similasan Corporation
Cigna
Viva Opti-Free
Clear eyes
Tears naturale
Systane
Refresh
Staples
Rite Aid
Murine
Walgreens

Based on type, the Antiviral Agents EyeDrops market is categorized into:

Ribavirin
Hydroxy benzyl azole
Cytidine
Others

According to applications, Antiviral Agents EyeDrops market splits into

Adult
Children

Global Antiviral Agents EyeDrops Market Regional Analysis:

The companies in the world that deals with Antiviral Agents EyeDrops mainly concentrate following regions.

RegionsSub Regions
North AmericaUSA, Canada and Mexico etc.
Asia-PacificChina, Japan, Korea, India, and Southeast Asia
The Middle East and AfricaSaudi Arabia, the UAE, Egypt, Turkey, Nigeria, and South Africa
EuropeGermany, France, the UK, Russia, and Italy
South AmericaBrazil, Argentina, Columbia, etc.
The Detailed competitive scenario of the global and United States Antiviral Agents EyeDrops market:

The report highlights objectives, missions, core business values, and niche markets of leading participants operating in the worldwide Antiviral Agents EyeDrops industry. It also facilitates clients with the acumen to gain competitive advantages in the Antiviral Agents EyeDrops market and the strengths and weaknesses of their strong opponents. The Antiviral Agents EyeDrops report underscores their strategic moves, including brand developments, promotional activities, and product launches, as well as ventures, acquisitions, amalgamations, and Antiviral Agents EyeDrops mergers as efforts to dilate their serving area and deliver better fit products to their customer base.

In the Antiviral Agents EyeDrops report, participants financial assessments are also included which consists of an evaluation of gross margin, sales volume, cash flow, revenue outcomes, capital investment, and Antiviral Agents EyeDrops growth rate which will allow clients to gain intact comprehension of participants financial strengths and position in the global Antiviral Agents EyeDrops market. Their production capacity, plant locations, manufacturing processes, production volume, product specifications, raw material sourcing, distribution networks, and global Antiviral Agents EyeDrops presence are also analyzed in the report.

Worldwide and United States Antiviral Agents EyeDrops market report coverage:

The report covers extensive analysis of the Antiviral Agents EyeDrops market scope, potential, structure, financial impacts and fluctuations. Extensive evaluation of Antiviral Agents EyeDrops market overview, establishment, history, as well as influential factors such as restraints, Antiviral Agents EyeDrops driving factors, limitations, and dynamics that can pose considerable impacts on Antiviral Agents EyeDrops market development rate. The report also enfolds the precise evaluation of Antiviral Agents EyeDrops market size, share, revenue, growth rate, and product & sales volume.

According to the statistics, the Antiviral Agents EyeDrops market is likely to report considerable revenue coupled with substantial growth during the forecast period as growing demand, increasing disposable incomes, raw material affluence, changing consumption tendencies, Antiviral Agents EyeDrops market trends, and stable market structure are fueling the growth of the global Antiviral Agents EyeDrops industry. The industry holds the potential to radically influence its peers and parent Antiviral Agents EyeDrops markets alongside the international financial system.

Why buy global and United States Antiviral Agents EyeDrops market report?

* Get a detailed picture of the Antiviral Agents EyeDrops market;
* Pinpoint Antiviral Agents EyeDrops growth sectors and identify factors driving change;
* Understand the Antiviral Agents EyeDrops competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the Antiviral Agents EyeDrops market is predicted to develop.

Moreover, the report organizes to provide essential information on current and future Antiviral Agents EyeDrops market movements, organizational needs and Antiviral Agents EyeDrops industrial innovations. Additionally, the complete Antiviral Agents EyeDrops report helps the new aspirants to inspect the forthcoming opportunities in the Antiviral Agents EyeDrops industry. Investors will get a clear idea of the dominant Antiviral Agents EyeDrops players and their future forecasts.

Furthermore, Antiviral Agents EyeDrops readers will get a clear perspective on the most affecting driving and restraining forces in the Antiviral Agents EyeDrops market and its impact on the global market. The report predicts the future outlook for Antiviral Agents EyeDrops market that will help the readers in making appropriate decisions on which Antiviral Agents EyeDrops market segments to focus in the upcoming years accordingly.

In a word, the Antiviral Agents EyeDrops report offers a whole consequential study of the parent Antiviral Agents EyeDrops market, key tactics followed by leading Antiviral Agents EyeDrops industry Players and upcoming segments. Likewise, the former and current Antiviral Agents EyeDrops industry forecast analysis in terms of volume and value along with research conclusions is a decisive part of Antiviral Agents EyeDrops study. So that Antiviral Agents EyeDrops report helps the new aspirants to inspect the forthcoming opportunities in the Antiviral Agents EyeDrops market.

Table of Content

Table of Contents

1 Market Overview
1.1 Antiviral Agents EyeDrops Introduction
1.2 Market Analysis by Type
1.2.1 Overview Global Antiviral Agents EyeDrops Revenue by Type 2015 VS 2019 VS 2025
1.2.2 Ribavirin
1.2.3 Hydroxy benzyl azole
1.2.4 Cytidine
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview Global Antiviral Agents EyeDrops Revenue by Application 2015 VS 2019 VS 2025
1.3.2 Adult
1.3.3 Children
1.4 Global Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
1.4.1 Global Antiviral Agents EyeDrops Revenue and Forecast (2015-2025)
1.4.2 Global Antiviral Agents EyeDrops Sales and Forecast (2015-2025)
1.5 Global Antiviral Agents EyeDrops Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis AG SWOT Analysis
2.1.4 Novartis AG Product and Services
2.1.5 Novartis AG Antiviral Agents EyeDrops Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Alcon
2.2.1 Alcon Details
2.2.2 Alcon Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Alcon SWOT Analysis
2.2.4 Alcon Product and Services
2.2.5 Alcon Antiviral Agents EyeDrops Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bausch Lomb Inc
2.3.1 Bausch Lomb Inc Details
2.3.2 Bausch Lomb Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bausch Lomb Inc SWOT Analysis
2.3.4 Bausch Lomb Inc Product and Services
2.3.5 Bausch Lomb Inc Antiviral Agents EyeDrops Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Allergan, Inc.
2.4.1 Allergan, Inc. Details
2.4.2 Allergan, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Allergan, Inc. SWOT Analysis
2.4.4 Allergan, Inc. Product and Services
2.4.5 Allergan, Inc. Antiviral Agents EyeDrops Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Visine
2.5.1 Visine Details
2.5.2 Visine Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Visine SWOT Analysis
2.5.4 Visine Product and Services
2.5.5 Visine Antiviral Agents EyeDrops Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Meda Pharmaceuticals Inc
2.6.1 Meda Pharmaceuticals Inc Details
2.6.2 Meda Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Meda Pharmaceuticals Inc SWOT Analysis
2.6.4 Meda Pharmaceuticals Inc Product and Services
2.6.5 Meda Pharmaceuticals Inc Antiviral Agents EyeDrops Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bausch Lomb
2.7.1 Bausch Lomb Details
2.7.2 Bausch Lomb Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bausch Lomb SWOT Analysis
2.7.4 Bausch Lomb Product and Services
2.7.5 Bausch Lomb Antiviral Agents EyeDrops Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Similasan Corporation
2.8.1 Similasan Corporation Details
2.8.2 Similasan Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Similasan Corporation SWOT Analysis
2.8.4 Similasan Corporation Product and Services
2.8.5 Similasan Corporation Antiviral Agents EyeDrops Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Cigna
2.9.1 Cigna Details
2.9.2 Cigna Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Cigna SWOT Analysis
2.9.4 Cigna Product and Services
2.9.5 Cigna Antiviral Agents EyeDrops Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Viva Opti-Free
2.10.1 Viva Opti-Free Details
2.10.2 Viva Opti-Free Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Viva Opti-Free SWOT Analysis
2.10.4 Viva Opti-Free Product and Services
2.10.5 Viva Opti-Free Antiviral Agents EyeDrops Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Clear eyes
2.11.1 Clear eyes Details
2.11.2 Clear eyes Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Clear eyes SWOT Analysis
2.11.4 Clear eyes Product and Services
2.11.5 Clear eyes Antiviral Agents EyeDrops Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Tears naturale
2.12.1 Tears naturale Details
2.12.2 Tears naturale Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Tears naturale SWOT Analysis
2.12.4 Tears naturale Product and Services
2.12.5 Tears naturale Antiviral Agents EyeDrops Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Systane
2.13.1 Systane Details
2.13.2 Systane Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Systane SWOT Analysis
2.13.4 Systane Product and Services
2.13.5 Systane Antiviral Agents EyeDrops Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Refresh
2.14.1 Refresh Details
2.14.2 Refresh Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Refresh SWOT Analysis
2.14.4 Refresh Product and Services
2.14.5 Refresh Antiviral Agents EyeDrops Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Staples
2.15.1 Staples Details
2.15.2 Staples Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Staples SWOT Analysis
2.15.4 Staples Product and Services
2.15.5 Staples Antiviral Agents EyeDrops Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Rite Aid
2.16.1 Rite Aid Details
2.16.2 Rite Aid Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Rite Aid SWOT Analysis
2.16.4 Rite Aid Product and Services
2.16.5 Rite Aid Antiviral Agents EyeDrops Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Murine
2.17.1 Murine Details
2.17.2 Murine Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Murine SWOT Analysis
2.17.4 Murine Product and Services
2.17.5 Murine Antiviral Agents EyeDrops Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Walgreens
2.18.1 Walgreens Details
2.18.2 Walgreens Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Walgreens SWOT Analysis
2.18.4 Walgreens Product and Services
2.18.5 Walgreens Antiviral Agents EyeDrops Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Antiviral Agents EyeDrops Market, Company Landscape
3.1 Company Market Share Analysis Global
3.1.1 Global Antiviral Agents EyeDrops Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Antiviral Agents EyeDrops Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis United States
3.2.1 Key Players Antiviral Agents EyeDrops Sales in United States (2018-2019)
3.2.2 United States Antiviral Agents EyeDrops Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Antiviral Agents EyeDrops Manufacturer Market Share in 2019
3.3.2 Top 6 Antiviral Agents EyeDrops Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Antiviral Agents EyeDrops Market Size by Geography (2015-2020)
4.1.1 Global Antiviral Agents EyeDrops Sales by Geography (2015-2020)
4.1.2 Global Antiviral Agents EyeDrops Revenue by Regions (2015-2020)
4.2 Global Antiviral Agents EyeDrops Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Antiviral Agents EyeDrops Sales and Forecast by Regions (2020-2025)
4.2.2 Global Antiviral Agents EyeDrops Revenue and Forecast by Regions (2020-2025)
4.3 North America Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
4.4 Europe Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
4.6 South America Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Antiviral Agents EyeDrops Market Size by Country (2015-2020)
5.1.1 North America Antiviral Agents EyeDrops Sales and Market Share by Country (2015-2020)
5.1.2 North America Antiviral Agents EyeDrops Revenue and Market Share by Country (2015-2020)
5.2 North America Antiviral Agents EyeDrops Market Size and Forecast by Country (2020-2025)
5.2.1 North America Antiviral Agents EyeDrops Sales and Forecast by Country (2020-2025)
5.2.2 North America Antiviral Agents EyeDrops Revenue and Forecast by Country (2020-2025)
5.3 United States Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
5.4 Canada Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
5.5 Mexico Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Antiviral Agents EyeDrops Market Size by Country (2015-2020)
6.1.1 Europe Antiviral Agents EyeDrops Sales by Country (2015-2020)
6.1.2 Europe Antiviral Agents EyeDrops Revenue by Country (2015-2020)
6.2 Europe Antiviral Agents EyeDrops Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Antiviral Agents EyeDrops Sales and Forecast by Country (2020-2025)
6.2.2 Europe Antiviral Agents EyeDrops Revenue and Forecast by Country (2020-2025)
6.3 Germany Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
6.4 United Kingdom Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
6.5 France Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
6.6 Russia Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
6.7 Italy Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Antiviral Agents EyeDrops Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Antiviral Agents EyeDrops Sales by Region (2015-2020)
7.1.2 Asia-Pacific Antiviral Agents EyeDrops Revenue by Region (2015-2020)
7.2 Asia-Pacific Antiviral Agents EyeDrops Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Antiviral Agents EyeDrops Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Antiviral Agents EyeDrops Revenue and Forecast by Region (2020-2025)
7.3 China Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
7.4 Japan Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
7.5 Korea Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
7.6 India Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
7.7 Southeast Asia Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
7.8 Australia Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Antiviral Agents EyeDrops Market Size by Country (2015-2020)
8.1.1 South America Antiviral Agents EyeDrops Sales by Country (2015-2020)
8.1.2 South America Antiviral Agents EyeDrops Revenue by Country (2015-2020)
8.2 South America Antiviral Agents EyeDrops Market Size and Forecast by Country (2020-2025)
8.2.1 South America Antiviral Agents EyeDrops Sales and Forecast by Country (2020-2025)
8.2.2 South America Antiviral Agents EyeDrops Revenue and Forecast by Country (2020-2025)
8.3 Brazil Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
8.4 Argentina Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
9 Middle East Africa by Countries
9.1 Middle East Africa Antiviral Agents EyeDrops Market Size by Country (2015-2020)
9.1.1 Middle East Africa Antiviral Agents EyeDrops Sales by Country (2015-2020)
9.1.2 Middle East Africa Antiviral Agents EyeDrops Revenue by Country (2015-2020)
9.2 Middle East Africa Antiviral Agents EyeDrops Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East Africa Antiviral Agents EyeDrops Sales and Forecast by Country (2020-2025)
9.2.2 Middle East Africa Antiviral Agents EyeDrops Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
9.4 Turkey Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
9.5 Egypt Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
9.6 South Africa Antiviral Agents EyeDrops Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Antiviral Agents EyeDrops Market Size by Type (2015-2020)
10.1.1 Global Antiviral Agents EyeDrops Sales by Type (2015-2020)
10.1.2 Global Antiviral Agents EyeDrops Revenue by Type (2015-2020)
10.1.3 Global Antiviral Agents EyeDrops Price by Type (2015-2020)
10.2 Global Antiviral Agents EyeDrops Market Size and Forecast by Type (2020-2025)
10.2.1 Global Antiviral Agents EyeDrops Sales and Forecast by Type (2020-2025)
10.2.2 Global Antiviral Agents EyeDrops Revenue and Forecast by Type (2020-2025)
10.2.3 Global Antiviral Agents EyeDrops Price and Forecast by Type (2020-2025)
10.3 United States Antiviral Agents EyeDrops Market Size and Forecast by Type (2015-2025)
10.3.1 United States Antiviral Agents EyeDrops Market Size by Type (2015-2020)
10.3.2 United States Antiviral Agents EyeDrops Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Antiviral Agents EyeDrops Market Size by Application (2015-2020)
11.1.1 Global Antiviral Agents EyeDrops Sales by Application (2015-2020)
11.1.2 Global Antiviral Agents EyeDrops Revenue by Application (2015-2020)
11.1.3 Global Antiviral Agents EyeDrops Price by Application (2015-2020)
11.2 Global Antiviral Agents EyeDrops Market Size and Forecast by Application (2020-2025)
11.2.1 Global Antiviral Agents EyeDrops Sales and Forecast by Application (2020-2025)
11.2.2 Global Antiviral Agents EyeDrops Revenue and Forecast by Application (2020-2025)
11.2.3 Global Antiviral Agents EyeDrops Price and Forecast by Application (2020-2025)
11.3 United States Antiviral Agents EyeDrops Market Size and Forecast by Application (2015-2025)
11.3.1 United States Antiviral Agents EyeDrops Market Size by Application (2015-2020)
11.3.2 United States Antiviral Agents EyeDrops Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

Request Sample

Request Sample

Discount

Discount